Gene mutations and actionable genetic lesions in mantle cell lymphoma.
about
A lowered 26S proteasome activity correlates with mantle lymphoma cell lines resistance to genotoxic stress.Current trials for frontline therapy of mantle cell lymphoma.The B cell receptor signaling pathway in mantle cell lymphoma.Abnormal microRNA expression in the course of hematological malignancies
P2860
Gene mutations and actionable genetic lesions in mantle cell lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene mutations and actionable genetic lesions in mantle cell lymphoma.
@en
Gene mutations and actionable genetic lesions in mantle cell lymphoma.
@nl
type
label
Gene mutations and actionable genetic lesions in mantle cell lymphoma.
@en
Gene mutations and actionable genetic lesions in mantle cell lymphoma.
@nl
prefLabel
Gene mutations and actionable genetic lesions in mantle cell lymphoma.
@en
Gene mutations and actionable genetic lesions in mantle cell lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Gene mutations and actionable genetic lesions in mantle cell lymphoma
@en
P2093
Krystle Nomie
Michael Wang
P2860
P304
58638-58648
P356
10.18632/ONCOTARGET.10716
P407
P5008
P577
2016-09-01T00:00:00Z